The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Open accessAbstract
As an essential innate immune population for maintaining body homeostasis and warding off foreign pathogens, macrophages display high plasticity and perform diverse supportive functions specialized to different tissue compartments. Consequently, aberrance in macrophage functions contributes substantially to progression of several diseases including cancer, fibrosis, and diabetes. In the context of cancer, tumor-associated macrophages (TAMs) in tumor microenvironment (TME) typically promote cancer cell proliferation, immunosuppression, and angiogenesis in support of tumor growth and metastasis. Oftentimes, the abundance of TAMs in tumor is correlated with poor disease prognosis. Hence, significant attention has been drawn towards development of cancer immunotherapies targeting these TAMs; either depleting them from tumor, blocking their pro-tumoral functions, or restoring their immunostimulatory/tumoricidal properties. This review aims to introduce readers to various aspects in development and evaluation of TAM-targeted therapeutics in pre-clinical and clinical stages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–223 of 223
Fend, L., Accart, N., Kintz, J., Cochin, S., Reymann, C., Pogam, F. L., Marchand, J.-B., Menguy, T., Slos, P., Rooke, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073310 · Cited by 62
Effective delivery of chemotherapeutic nanoparticles by depleting host Kupffer cells
Ohara, Y., Oda, T., Yamada, K., Hashimoto, S., Akashi, Y., Miyamoto, R., Kobayashi, A., Fukunaga, K., Sasaki, R., & Ohkohchi, N. (2012) · International Journal of Cancer · doi:10.1002/ijc.27502 · Cited by 61
Jeong, W., Doroshow, J. H., & Kummar, S. (2013) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2013.06.001 · Cited by 59
Weiskopf, K., Anderson, K. L., Ito, D., Schnorr, P. J., Tomiyasu, H., Ring, A. M., Bloink, K., Efe, J. A., Rue, S. M., Lowery, D. E., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0105 · Cited by 59
Bryniarski, K., Szczepanik, M., Ptak, M., Zemelka‐Wiącek, M., & Ptak, W. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70098-2 · Cited by 55
I-SPY 2 — Toward More Rapid Progress in Breast Cancer Treatment
Carey, L., & Winer, E. P. (2016) · New England Journal of Medicine · doi:10.1056/nejme1603691 · Cited by 54
Myeloid-Specific Expression of Ron Receptor Kinase Promotes Prostate Tumor Growth
Gurusamy, D., Gray, J. K., Pathrose, P., Kulkarni, R. M., Finkleman, F. D., & Waltz, S. E. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2474 · Cited by 53
Molecular Imaging of Folate Receptor β–Positive Macrophages during Acute Lung Inflammation
Han, W., Zaynagetdinov, R., Yull, F. E., Polosukhin, V. V., Gleaves, L. A., Tanjore, H., Young, L. R., Peterson, T. E., Manning, H. C., Prince, L. S., et al. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0289oc · Cited by 51
Taylor, R. P., & Lindorfer, M. A. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.092684 · Cited by 50
Hattori, Y., Yamashita, J., Sakaida, C., Kawano, K., & Yonemochi, E. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2014.954128 · Cited by 49
Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep)
Ngambenjawong, C., Gustafson, H. H., Pineda, J. M., Kacherovsky, N. A., Cieslewicz, M., & Pun, S. H. (2016) · Theranostics · doi:10.7150/thno.15394 · Cited by 48
Self-citationLutz, M. A., & Correll, P. H. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602319 · Cited by 47
Coutelle, O., Schiffmann, L. M., Liwschitz, M., Brunold, M., Goede, V., Hallek, M. J., Kashkar, H., & Hacker, U. T. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.629 · Cited by 40
Céspedes, M. V., Guillén, M. J., Lopez-Casas, P. P., Sarno, F., Gallardo, A., Álamo, P., Cuevas, C., Hidalgo, M. M., Galmarini, C. M., Allavena, P., et al. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.026369 · Cited by 38
Regulation of Macrophage Polarization by RON Receptor Tyrosine Kinase Signaling
Chaudhuri, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00546 · Cited by 37
Engineering an Affinity-Enhanced Peptide through Optimization of Cyclization Chemistry
Ngambenjawong, C., Pineda, J. M. B., & Pun, S. H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00502 · Cited by 37
Self-citationZhang, H., Zhang, W., Sun, X., Dang, R., Zhou, R., Bai, H., Ben, J., Zhu, X., Zhang, Y., Yang, Q., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10318 · Cited by 36
Bieniasz, M., Radhakrishnan, P., Faham, N., Jean–Paul De La, O., & Welm, A. L. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3283 · Cited by 35
Golani, L. K., Wallace-Povirk, A., Deis, S. M., Wong-Roushar, J., Ke, J., Gu, X., Raghavan, S., Wilson, M. R., Li, X., Polin, L., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00594 · Cited by 33
Chang, Y., Guo, H., Li, J., Song, Y., Zhang, M., Jin, J., Xing, G., & Zhao, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076024 · Cited by 32
Furusho, Y., Miyata, M., Matsuyama, T., Nagai, T., Li, H., Akasaki, Y., Hamada, N., Miyauchi, T., Ikeda, Y., Shirasawa, T., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.003079 · Cited by 25
Zoledronic acid enhances antitumor efficacy of liposomal doxorubicin
Hattori, Y., SHIBUYA, K., Kojima, K., Miatmoko, A., Kawano, K., Ozaki, K., & Yonemochi, E. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2991 · Cited by 21
Kogan, M., Fischer, T., Kaminsky, R., Lehmicke, G., & Rappaport, J. (2012) · PubMed · Cited by 13
Cited by
Immunotherapy in colorectal cancer: Rationale, challenges and potential
Ganesh, K., Stadler, Z. K., Cercek, A., Mendelsohn, R. B., Shia, J., Segal, N. H., & Diaz, L. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0126-x · Cited by 1,954
Tumor-Associated Macrophages in Tumor Immunity
Pan, Y., Yu, Y., Wang, X., & Zhang, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583084 · Cited by 1,872
Tumor-associated macrophages: an accomplice in solid tumor progression
Chen, Y., Song, Y., Du, W., Gong, L., Chang, H., & Zou, Z. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0568-z · Cited by 1,096
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
Yang, M., Li, J., Gu, P., & Fan, X. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.010 · Cited by 670
Metadata
- Authors
- Ngambenjawong, C., Gustafson, H. H., & Pun, S. H.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 114
- Pages
- 206-221
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2609512644
- Cited by
- 840
- References
- 223
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.